x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Diabetes Insights - Breakthroughs and Innovators

EASD - European Association for the Study of Diabetes

EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at the EASD Annual Meeting 2024 in Madrid, Spain

science

All Episodes

12:37

SURPASSing Therapeutic Challenges of Paediatric Type...

Diabetes Insights - Breakthroughs and Innovators ·

2025/12/19

In this episode, Dr. Tamara Hannon (Indiana University Health) and Prof. Martin Wabitsch (Universtätsklinikum Ulm) unpack the findings of the SURPASS-PEDS trial - the first study to evaluate the dual GIP/GLP-1 receptor agonist tirzepatide in adolescents with type 2 diabetes.With youth-onset type 2 diabetes rising sharply across the US and Europe, and with young people experiencing faster beta-cell decline, more severe obesity, and greater socioeconomic burdens, the need for effective therapies has

en

16:19

The EASD's First Clinical Guideline: Assessment and...

Diabetes Insights - Breakthroughs and Innovators ·

2025/12/12

In this episode, EASD presents its inaugural clinical guideline on diabetes distress. Drawing on two years of multidisciplinary work, the guideline was developed by clinicians, methodologists, psychologists and people with lived experience. Prof. Jane Speight, Prof. Richard Holt and patient-advocate Michelle Law describe what diabetes distress is (the emotional burden tied to daily self-management) and why routine assessment and supportive care must become part of standard practice.The guideline

en

14:16

Population Level Screening to Detect Early Stage Type...

Diabetes Insights - Breakthroughs and Innovators ·

2025/12/05

In this episode, leading experts Anette Ziegler (Helmholtz Munich), Chantal Mathieu (KU Leuven & EASD President), and Anastasia Albanese-O’Neill (Breakthrough T1D) join EASD TV to discuss the emerging global consensus on screening for early-stage type 1 diabetes.They explore why population-wide screening is now considered both feasible and essential, how early detection can prevent DKA and enable access to disease-modifying therapies, and what the new guidance means for clinicians, health systems,

en

8:11

Results from the SOUL Trial: The Cardiologists'...

Diabetes Insights - Breakthroughs and Innovators ·

2025/11/28

Last week we heard the diabetologist's perspective on cardiovascular outcomes. In this weeks episode, EASD TV continues its deep dive into major clinical trials with the cardiologist’s perspective. Cardiologist Dr. Matthew Cavender (University of North Carolina) joins Vivienne Parry to unpack the SOUL trial, a major cardiovascular outcomes study evaluating oral semaglutide in people with type 2 diabetes.The trial followed more than 8,000 high-risk participants and demonstrated a 14% reduction in

en

8:50

Results from the SOUL Trial: The Diabetologists'...

Diabetes Insights - Breakthroughs and Innovators ·

2025/11/21

At the EASD 2024 Annual Meeting, the SOUL trial attracted significant attention as the first study to show cardiovascular risk reduction using an oral GLP-1 receptor agonist. In this episode, Dr Rodica Busui (Oregon Health & Science University-OHSU, Oregon, USA) explains the trial’s major outcomes, including a 14% reduction in major adverse cardiovascular events -matching results previously observed with injectable GLP-1 formulations.The discussion highlights the potential impact of an oral agent

en

12:22

ATTAIN-1 - Investigating Orforglipron for Obesity...

Diabetes Insights - Breakthroughs and Innovators ·

2025/11/14

In this episode, Dr. Sean Wharton (University of Toronto and Wharton Medical Clinic, Canada) and Dr. Nasreen Alfaris (King Fahad Medical City, Riyadh, Saudi Arabia) join host Vivienne Parry to discuss the groundbreaking ATTAIN trial, presented at the EASD 2025 Annual Meeting in Vienna. The trial tested Orforglipron, the first oral small molecule GLP-1 receptor agonist, showing promising results in weight reduction and cardiometabolic improvements among people living with overweight or

en

5:23

Pancreas Development: A Key to Discover Unexpected...

Diabetes Insights - Breakthroughs and Innovators ·

2025/11/07

What does the future hold for beta cell biology and diabetes treatment? Join Prof. Raphaël Scharfmann (INSERM), recipient of the 2025 Albert Renold Prize, as he explores how developmental biology is unlocking new ways to generate functional beta cells - an important step toward curing diabetes.In this inspiring interview from the EASD 2025 Annual Meeting in Vienna, Prof. Scharfmann discusses the progress in stem cell-derived beta cell generation, the collaboration driving translational research,

en

14:05

EASD-EFSD Rising Stars: The Future of Diabetes Research

Diabetes Insights - Breakthroughs and Innovators ·

2025/10/31

In this episode, Vivienne Parry introduces the EASD Rising Stars of 2025, four early-career researchers whose work spans exercise physiology, precision diabetes medicine, childhood obesity, and metabolic biology.Dr Sindre Lee-Ødegård (Norway) explores exercise as medicine for highrisk groups; Dr Martin Schön (Slovakia/Germany) works on precision diabetes diagnosis and lifestyle interventions; Dr Cadenas-Sánchez (Spain) investigates childhood obesity and brain health; and Dr Jens Lund (Denmark)

en

14:41

Impacting Lives of People with Diabetes in Resource...

Diabetes Insights - Breakthroughs and Innovators ·

2025/10/24

In this episode, Dr. Viswanathan Mohan, recipient of the inaugural EASD Global Impact Prize, reflects on his remarkable 50-year career transforming diabetes care in India and worldwide. From pioneering diabetes as a medical speciality and training over 29,000 educators, to leading translational research and nationwide screening initiatives, Dr. Mohan’s work has set new benchmarks in global health impact.He discusses the evolving causes of India’s diabetes epidemic, from genetics and

en

12:16

Everything you want to know about Adipose Tissue:...

Diabetes Insights - Breakthroughs and Innovators ·

2025/10/17

In this episode, EASD TV host Vivienne Parry sits with Prof. Mikael Rydén (Karolinska Institute), recipient of the 40th Camillo Golgi Prize, about his groundbreaking research on adipose tissue. Prof. Rydén shares insights into how different fat cell subtypes influence disease progression, particularly in diabetes and obesity. His work highlights the potential of precision medicine in tailoring treatments based on the composition of adipose tissue, shifting the focus from generalised treatments to

en

8:28

Back to the future: Re-centring the Role of the...

Diabetes Insights - Breakthroughs and Innovators ·

2025/10/10

In this episode, Dr Teresa Mezza, recipient of the 2025 EASD Minkowski Prize, takes listeners inside her pioneering research on the early mechanisms of type 2 diabetes. As both a clinician and researcher at the Fondazione Policlinico Universitario A. Gemelli in Rome, Dr Mezza studies patients before and after partial pancreatectomy, offering a unique perspective on beta cell adaptation, function, and decline.Her work is revealing early biomarkers that could identify individuals at risk of diabetes

en

9:41

Precision Diabetes: Learning From the Rare and...

Diabetes Insights - Breakthroughs and Innovators ·

2025/10/02

In this episode, EASD host, Vivienne Parry sits down with 2025 EASD Claude Bernard Prize recipient, Prof. Andrew Hattersley, to reflect on his career which has transformed diabetes research and care worldwide. From the discovery of key genetic mutations in maturity onset diabetes of the young (MODY) and neonatal diabetes to establishing a global genetic testing programme that has helped patients in more than 100 countries, Prof. Hattersley has shaped our understanding of diabetes. Tune in to hear

en

8:25

Mitochondria, Insulin Resistance, and the Future of...

Diabetes Insights - Breakthroughs and Innovators ·

2025/09/25

In this episode, we meet Prof Gerald Shulman, recipient of this year’s EASD-Novo Nordisk Foundation Diabetes Prize for Excellence, whose pioneering research has reshaped our understanding of insulin resistance and its role in type 2 diabetes and beyond.Prof. Shulman shares insights from over four decades of research into how ectopic lipid accumulation disrupts insulin signalling, leading to diabetes, fatty liver disease, cardiovascular complications, cancers, and Alzheimer’s disease. He explains

en

11:54

The Future of Diabetes Technology: Beyond Devices to...

Diabetes Insights - Breakthroughs and Innovators ·

2025/07/04

In this special episode, host Vivienne Parry is joined by experts Anna Krook (Karolinska Institute), Klemen Dovč (Ljubljana University Medical Centre), Peter Gillard (University Hospital Leuven), and Julia Mader (University of Graz) to explore the rapid evolution of diabetes technology.From continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems to AI-powered apps and integrated health records, the panel discusses how these innovations are transforming care and what

en

11:29

Can Pre-Diabetes Remission Reduce Global Diabetes...

Diabetes Insights - Breakthroughs and Innovators ·

2025/06/27

In this episode, Dr Andreas Birkenfeld (Germany) and Dr Viswanathan Mohan, 1st EASD Diabetes Global Impact Prize winner (India), join host Vivienne Parry to explore the growing importance of recognising, screening and managing pre-diabetes on a global scale.They discuss how moving beyond diabetes remission to pre-diabetes remission could prevent long-term complications, and why strategic, risk-based screening could ease the economic burden on health systems. From policy change and health economics

en

19:46

What Will the Future Bring for People Living with...

Diabetes Insights - Breakthroughs and Innovators ·

2025/06/20

What does the future hold for people living with diabetes? In this episode, our host Vivienne Parry together with diabetes advocates Bastian Hauck, Renza Scibilia and Christian Collin dives into recent advances in diabetes prevention, screening, and therapeutics - from GLP-1 drugs to innovative community-driven screening strategies. But as science accelerates, can our health systems and societies keep up? Join us for an eye-opening conversation on equity, access, and the power of community in

en

11:16

Will Next Generation Obesity Drugs make Bariatric...

Diabetes Insights - Breakthroughs and Innovators ·

2025/06/13

In this lively episode of Diabetes Insights, Prof. Francesco Rubino (King’s College London) and Dr. Louis Aronne (Weill Cornell Medicine) join Vivienne Parry to debate one of the biggest questions in obesity care: will next-generation medications make bariatric surgery obsolete?Drawing on decades of clinical experience and new trial evidence, they explore whether powerful GLP-1-based therapies and combination drugs can rival the life-changing outcomes of surgery. From costs and complications to

en

20:47

Breaking Barriers: Public-Private Partnerships...

Diabetes Insights - Breakthroughs and Innovators ·

2025/06/06

In this episode, Dr. Melissa Thomas (Eli, Lilly & Company), Dr. Elizabeth Niemoller (Sanofi) and Prof. Michele Solimena (Helmholtz Zentrum München & Technical University of Dresden) join host Vivienne Parry to examine how partnerships between academia and industry are transforming diabetes research and care.They discuss the culture shift from cautious collaboration to dynamic, mission-driven partnerships and how initiatives like INNODIA and the Innovative Medicines Initiative (IMI) are delivering

en

9:14

Producing Beta Cells: Generation of Pancreatic islets...

Diabetes Insights - Breakthroughs and Innovators ·

2025/05/30

Today on Diabetes Insights, Prof. Raphael Scharfmann (INSERM, France) and Dr. Valeria Sordi (San Raffaele Diabetes Research Institute, Italy) join our host, Vivienne Parry to discuss the progress and remaining challenges in creating functional, insulin-producing beta cells from stem cells.From the fundamental biology of pancreatic development to translational protocols for generating clinical-grade cells, our experts highlight how far the field has advanced and what hurdles remain before cell

en

15:31

Advances in Diabetes Care: Technology in Hospitals,...

Diabetes Insights - Breakthroughs and Innovators ·

2025/05/23

In this episode, Professors Hood Thabit (University of Manchester, UK) and Helen Murphy (University of East Anglia, Norwich, UK) join Vivienne Parry and EASD to discuss the opportunities and persistent challenges in diabetes care in hospitals and pregnancy.The conversation examines how diabetes technology - from continuous glucose monitoring (CGM) to hybrid closed-loop systems - is improving outcomes for people with diabetes in inpatient settings and for pregnant women with type 1 diabetes. The

en

45 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter